The estimated Net Worth of Ebetuel Pallares is at least 451 千$ dollars as of 11 March 2020. Ebetuel Pallares owns over 24,692 units of Exagen Inc stock worth over 437,068$ and over the last 5 years he sold XGN stock worth over 0$. In addition, he makes 14,375$ as Independent Director at Exagen Inc.
Ebetuel has made over 1 trades of the Exagen Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 24,692 units of XGN stock worth 45,433$ on 11 March 2020.
The largest trade he's ever made was exercising 24,692 units of Exagen Inc stock on 11 March 2020 worth over 45,433$. On average, Ebetuel trades about 3,527 units every 0 days since 2019. As of 11 March 2020 he still owns at least 144,247 units of Exagen Inc stock.
You can see the complete history of Ebetuel Pallares stock trades at the bottom of the page.
Dr. Ebetuel Pallares serves as Independent Director of the Company. Dr. Pallares founded Proficio Capital Management (PCM), LLC, a seed and early-stage venture fund headquartered in El Paso, TX, and he has served as its General Partner since that time. Through PCM, Dr. Pallares manages several investments, including PCM/Exagen L.P. In June 2009, he co-founded Cottonwood Capital Partners, the general partner of Cottonwood Technology Fund, a seed and early-stage venture fund with headquarters in El Paso, Texas, and he served as its Managing Partner until December 2014. In 2006, Dr. Pallares founded Joseph Advisory Services, LLC, a strategic consulting firm, and has served as its Manager since that time. He also currently manages investments on behalf of a family office, managing fund commitments and direct investments into private operating companies. His investment sectors span healthcare, medical diagnostics, therapeutics, IT, materials sciences and nanotechnology, education technology, AR/VR and financial technology companies. Dr. Pallares also serves on several corporate and non-profit boards, as an advisor to the UT Horizon Fund, the venture capital investment fund of the University of Texas system, as an Investor in Residence for New Mexico State University’s Arrowhead Center and on the limited partnership advisory committee for several venture funds. Dr. Pallares’s extensive venture capital experience and his service as a director for numerous companies contributed to our Board's conclusion that he should serve as a director of our company.
As the Independent Director of Exagen Inc, the total compensation of Ebetuel Pallares at Exagen Inc is 14,375$. There are 10 executives at Exagen Inc getting paid more, with Fortunato Rocca having the highest compensation of 1,627,720$.
Ebetuel Pallares is 46, he's been the Independent Director of Exagen Inc since 2012. There are 11 older and 3 younger executives at Exagen Inc. The oldest executive at Exagen Inc is James Tullis, 72, who is the Independent Director.
Ebetuel's mailing address filed with the SEC is C/O EXAGEN INC., 1261 LIBERTY WAY, VISTA, CA, 92081.
Over the last 5 years, insiders at Exagen Inc have traded over 8,628,989$ worth of Exagen Inc stock and bought 556,568 units worth 6,283,309$ . The most active insiders traders include James L L Tullis、Bio Exagen, L.P.H.I.G. Gpii...、Jeffrey Thomas Elliott. On average, Exagen Inc executives and independent directors trade stock every 48 days with the average trade being worth of 109,189$. The most recent stock trade was executed by John Aballi on 16 May 2024, trading 40,401 units of XGN stock currently worth 77,570$.
exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.
Exagen Inc executives and other stock owners filed with the SEC include: